Perceptive Advisors Llc Buys Invitae Corp, Horizon Therapeutics PLC, Atea Pharmaceuticals Inc, Sells MyoKardia Inc, CRISPR Therapeutics AG, Immunomedics Inc

• New Purchases: NVTA, HZNP, AVIR, KRON, ARWR, CERE, ONCR, SAGE, RAPT, LUNG, ANAB, FDMT, PCVX, NSTG, RGEN, SCYX, NBTX, FBRX, MRVI, CRIS, SHC, SNDX, PHR, SGTX, PTGX, AVXL, MASS, ABCL, IPOF, DFHT,
• Added Positions: RCKT, MRTX, SWTX, NVAX, NBIX, SLDB, NVRO, REGN, CHRS, PMVP, ACCD, VERU, COGT, UROV, ONEM, MGTX, ISEE, TVTX, NEPT, ADPT, HRMY, AMWL, ESTA,
• Reduced Positions: IOVA, MTEM, KOD, NARI, GBT, ZYME, ARNA, SILK, AQST, DBVT, HCAT, MGNX,
• Sold Out: MYOK, CRSP, IMMU, BPMC, TPTX, HOLX, ATRC, TWST, PODD, LSACU, TBIO, ATEC, TRIL, LVGO, TGTX, REPL, CVET, PSNL, AKRO, CLDX, BIO,

For the details of PERCEPTIVE ADVISORS LLC's stock buys and sells, go to https://www.gurufocus.com/guru/perceptive+advisors+llc/current-portfolio/portfolio

1. Mirati Therapeutics Inc (MRTX) - 3,693,516 shares, 9.82% of the total portfolio. Shares added by 7.51%
2. Amicus Therapeutics Inc (FOLD) - 25,112,048 shares, 7.02% of the total portfolio. Shares reduced by 0.04%
3. BridgeBio Pharma Inc (BBIO) - 6,706,268 shares, 5.77% of the total portfolio.
4. Iovance Biotherapeutics Inc (IOVA) - 9,166,304 shares, 5.15% of the total portfolio. Shares reduced by 9.12%
5. Invitae Corp (NVTA) - 7,284,466 shares, 3.69% of the total portfolio. New Position

Perceptive Advisors Llc initiated holding in Invitae Corp. The purchase prices were between $39.09 and $57.4, with an estimated average price of $47.83. The stock is now traded at around $49.070000. The impact to a portfolio due to this purchase was 3.69%. The holding were 7,284,466 shares as of 2020-12-31.

Perceptive Advisors Llc initiated holding in Horizon Therapeutics PLC. The purchase prices were between $67 and $84.39, with an estimated average price of $74.23. The stock is now traded at around $86.960000. The impact to a portfolio due to this purchase was 2.73%. The holding were 3,084,042 shares as of 2020-12-31.

Perceptive Advisors Llc initiated holding in Atea Pharmaceuticals Inc. The purchase prices were between $26.36 and $41.78, with an estimated average price of $32.23. The stock is now traded at around $84.150000. The impact to a portfolio due to this purchase was 1.57%. The holding were 3,109,224 shares as of 2020-12-31.

Perceptive Advisors Llc initiated holding in Kronos Bio Inc. The purchase prices were between $26.68 and $38.23, with an estimated average price of $31.37. The stock is now traded at around $28.820000. The impact to a portfolio due to this purchase was 1%. The holding were 2,780,097 shares as of 2020-12-31.

Perceptive Advisors Llc initiated holding in Arrowhead Pharmaceuticals Inc. The purchase prices were between $43.82 and $85.37, with an estimated average price of $64.25. The stock is now traded at around $87.400000. The impact to a portfolio due to this purchase was 0.99%. The holding were 1,070,814 shares as of 2020-12-31.

Perceptive Advisors Llc initiated holding in Cerevel Therapeutics Holdings Inc. The purchase prices were between $0 and $18.27, with an estimated average price of $13.97. The stock is now traded at around $14.760000. The impact to a portfolio due to this purchase was 0.91%. The holding were 4,544,062 shares as of 2020-12-31.

Perceptive Advisors Llc added to a holding in Rocket Pharmaceuticals Inc by 55.18%. The purchase prices were between $23.31 and $59.57, with an estimated average price of $36.66. The stock is now traded at around $54.260000. The impact to a portfolio due to this purchase was 0.8%. The holding were 3,396,867 shares as of 2020-12-31.

Perceptive Advisors Llc added to a holding in SpringWorks Therapeutics Inc by 20.01%. The purchase prices were between $48.36 and $77.92, with an estimated average price of $64.62. The stock is now traded at around $88.820000. The impact to a portfolio due to this purchase was 0.61%. The holding were 4,177,721 shares as of 2020-12-31.

Perceptive Advisors Llc added to a holding in Novavax Inc by 47.38%. The purchase prices were between $78.74 and $139.5, with an estimated average price of $106.31. The stock is now traded at around $262.700000. The impact to a portfolio due to this purchase was 0.45%. The holding were 1,043,000 shares as of 2020-12-31.

Perceptive Advisors Llc added to a holding in Neurocrine Biosciences Inc by 22.63%. The purchase prices were between $86.91 and $108.33, with an estimated average price of $96.57. The stock is now traded at around $112.410000. The impact to a portfolio due to this purchase was 0.41%. The holding were 1,899,215 shares as of 2020-12-31.

Perceptive Advisors Llc added to a holding in Solid Biosciences Inc by 60.06%. The purchase prices were between $3.08 and $7.79, with an estimated average price of $4.23. The stock is now traded at around $7.250000. The impact to a portfolio due to this purchase was 0.37%. The holding were 10,803,857 shares as of 2020-12-31.

Perceptive Advisors Llc added to a holding in Regeneron Pharmaceuticals Inc by 1003.50%. The purchase prices were between $478.3 and $607.98, with an estimated average price of $539.35. The stock is now traded at around $480.710000. The impact to a portfolio due to this purchase was 0.29%. The holding were 55,175 shares as of 2020-12-31.

Perceptive Advisors Llc sold out a holding in MyoKardia Inc. The sale prices were between $139.6 and $224.91, with an estimated average price of $220.55.

Perceptive Advisors Llc sold out a holding in CRISPR Therapeutics AG. The sale prices were between $79.67 and $173.23, with an estimated average price of $118.75.

Perceptive Advisors Llc sold out a holding in Immunomedics Inc. The sale prices were between $85.08 and $87.86, with an estimated average price of $86.65.

Perceptive Advisors Llc sold out a holding in Blueprint Medicines Corp. The sale prices were between $92.08 and $124.48, with an estimated average price of $105.57.

Perceptive Advisors Llc sold out a holding in Turning Point Therapeutics Inc. The sale prices were between $88.19 and $130.94, with an estimated average price of $109.9.

Perceptive Advisors Llc sold out a holding in Hologic Inc. The sale prices were between $65.85 and $76.67, with an estimated average price of $70.66.